Where To Report Waste

Fraud, Abuse, Or Retaliation

Evaluation of the U.S. Marshals Service’s Pharmaceutical Drug Costs and Procurement Process

Submitting OIG:

Department of Justice OIG

Date Issued:

Wednesday, December 21, 2022

Agency Reviewed / Investigated:

Department of Justice

Submitting OIG-Specific Report Number:

23-014

Component, if applicable:

United States Marshals Service

Location(s):

Agency-Wide

Type of Report:

Inspection / Evaluation

Questioned Costs:

$0

Funds for Better Use:

$0

View Document:

Attachment	Size
23-014.pdf	2.54 MB

Related Open Recommendations

Recommendation Number	Recommendation Status	Significant Recommendation	Additional Details
1	Open	No	https://oig.justice.gov/reports
Conduct additional market research to test the existing assumption that combining Pharmacy Program and non-Pharmacy Program tasks into one contract is the most cost-effective method to provide quality healthcare to USMS detainees
2	Open	No	https://oig.justice.gov/reports
Seek to incorporate into the National Managed Care Contract Pharmacy Program cost-reporting requirements that would allow the USMS to determine whether the prices it pays for drugs are comparable to the Federal Supply Schedule, to negotiate lower drug prices, and to assess whether alternative contract types and pricing schedules might reduce overall drug and drug delivery costs.
3	Open	No	https://oig.justice.gov/reports
Consider implementing a process by which it could proactively advise on the procurement of high-priced drugs before such drugs are purchased by non-Pharmacy Program intergovernmental agreement facilities.